NSEAnalysts/Institutional Investor Meet/Con. Call Updates8 Sept 2026 · 8 Sept 2026, 07:45 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Gland Pharma Limited · GLAND
✦ AI Summary
Gland Pharma Limited has informed the Exchange about the schedule of Analyst/Institutional Investor Meetings, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
GLAND_08092026194223_Analyst_Institutional_Investor_Meet_11092026.pdf
View document text
September 08, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relationship Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor
25th floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Bandra
Mumbai - 400 001 (East), Mumbai - 400 051
Scrip Code: 543245 Symbol: GLAND (ISIN: INE068V01023)
Dear Sir/Madam,
Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015; please find below the schedule of the Analyst/ Institutional
Investor Meetings with the Company:
Date Investor/Analyst/Fund Name Type of Meeting
September 11, 2026 DSP Mutual Fund One-on-One Meeting
The schedule of the above-mentioned meetings is subject to change, and the change may occur due to
exigencies on the part of the Investor/ Analyst/ Company.
This is for your information and records.
Yours truly,
For Gland Pharma Limited
Sampath Kumar Pallerlamudi
Company Secretary & Compliance Officer